Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q4 EPS of ($0.52), $0.15 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $5.23 million versus the consensus estimate of $4.82 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.